Download PDF
Klinische Neurophysiologie 2009; 40(1): 3-16
DOI: 10.1055/s-0028-1090207
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Amyotrophe Lateralsklerose

Amyotrophic Lateral SclerosisK.  Kollewe, S.  Petri
Further Information

Publication History

Publication Date:
18 March 2009 (online)

Also available at
    Permissions and Reprints

Lernziele

Klinisches Bild und unterschiedliche Verlaufsformen der amyotrophen Lateralsklerose (ALS) Klinische, elektrophysiologische, laborchemische, bildgebende Diagnostik Möglichkeiten der neuroprotektiven und insbesondere der symptomatischen Therapie

Literatur

  • 1 Bruijn L I, Miller T M, Cleveland D W. Unraveling the mechanisms involved in motor neuron degeneration in ALS.  Annu Rev Neurosci. 2004;  27 723-749
    CrossrefPubMedGoogle Scholar
  • 2 Rosen D. et al . Mutations in Cu / Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.  Nature. 1993;  362 59-62
    CrossrefPubMedGoogle Scholar
  • 3 Pasinelli P, Brown R H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.  Nat Rev Neurosci. 2006;  7 710-723
    CrossrefPubMedGoogle Scholar
  • 4 Cronin S. et al . A genome-wide association study of sporadic ALS in a homogenous Irish population.  Hum Mol Genet. 2008;  17 768-774
    PubMedGoogle Scholar
  • 5 Cronin S. et al . Screening for replication of genome-wide SNP associations in sporadic ALS.  Eur J Hum Genet. 2009;  17 213-218
    CrossrefPubMedGoogle Scholar
  • 6 Schymick J C. et al . Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.  Lancet Neurol. 2007;  6 322-328
    CrossrefPubMedGoogle Scholar
  • 7 Traynor B J, Singleton A. Genome-wide association studies and ALS: are we there yet?.  Lancet Neurol. 2007;  6 841-843
    CrossrefPubMedGoogle Scholar
  • 8 van Es M A. et al . ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.  Lancet Neurol. 2007;  6 869-877
    CrossrefPubMedGoogle Scholar
  • 9 van Es M A. et al . Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis.  Nat Genet. 2008;  40 29-31
    PubMedGoogle Scholar
  • 10 Muller-Jensen A, Bernhardt W. [Myatrophic lateralsclerosis].  Nervenarzt. 1973;  44 143-149
    PubMedGoogle Scholar
  • 11 Czaplinski A. et al . Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis.  Eur J Neurol. 2004;  11 567-568
    CrossrefPubMedGoogle Scholar
  • 12 Norris F H, Smith R A, Denys E H. Motor neurone disease: towards better care.  Br Med J (Clin Res Ed). 1985;  291 259-262
    PubMedGoogle Scholar
  • 13 McCullagh S. et al . Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction.  J Neurol Sci. 1999;  169 43-48
    CrossrefPubMedGoogle Scholar
  • 14 Younger D S. et al . Primary lateral sclerosis. A clinical diagnosis reemerges.  Arch Neurol. 1988;  45 1304-1307
    PubMedGoogle Scholar
  • 15 Brugman F. et al . Primary lateral sclerosis as a phenotypic manifestation of familial ALS.  Neurology. 2005;  64 1778-1779
    CrossrefPubMedGoogle Scholar
  • 16 Misuri G. et al . Mechanism of CO(2) retention in patients with neuromuscular disease.  Chest. 2000;  117 447-453
    CrossrefPubMedGoogle Scholar
  • 17 Piquet M A. [Nutritional approach for patients with amyotrophic lateral sclerosis].  Rev Neurol (Paris). 2006;  162, Spec No 2 4S177-4S187
    PubMedGoogle Scholar
  • 18 Funalot B. et al . High metabolic level in patients with familial amyotrophic lateral sclerosis.  Amyotroph Lateral Scler. 2008;  16 1-5
    PubMedGoogle Scholar
  • 19 Ringholz G M. et al . Prevalence and patterns of cognitive impairment in sporadic ALS.  Neurology. 2005;  65 586-590
    CrossrefPubMedGoogle Scholar
  • 20 Ringholz G M, Greene S R. The relationship between amyotrophic lateral sclerosis and frontotemporal dementia.  Curr Neurol Neurosci Rep. 2006;  6 387-392
    CrossrefPubMedGoogle Scholar
  • 21 Kurt A. et al . Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.  CNS Drugs. 2007;  21 279-291
    CrossrefPubMedGoogle Scholar
  • 22 Brooks B R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases / Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial . „Clinical limits of amyotrophic lateral sclerosis” workshop contributors.  J Neurol Sci. 1994;  124 (Suppl.) 96-107
    CrossrefPubMedGoogle Scholar
  • 23 Brooks B R. et al . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 293-299
    CrossrefPubMedGoogle Scholar
  • 24 Chio A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.  J Neurol. 1999;  246 (Suppl. 3) III1-5
    PubMedGoogle Scholar
  • 25 Chio A. Update on ISI survey: Europe, North America and South America.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 (Suppl. 1) S9-11
    CrossrefPubMedGoogle Scholar
  • 26 Andersen P M. et al . EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.  Eur J Neurol. 2005;  12 921-938
    CrossrefPubMedGoogle Scholar
  • 27 Andersen P M. et al . Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.  Amyotroph Lateral Scler. 2007;  8 195-213
    CrossrefPubMedGoogle Scholar
  • 28 Dengler R, Troger M. Classification of ALS – do we know enough?.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 68-69
    PubMedGoogle Scholar
  • 29 Troger M, Dengler R. The role of electromyography (EMG) in the diagnosis of ALS.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 (Suppl. 2) S33-40
    CrossrefPubMedGoogle Scholar
  • 30 Dengler R. et al . Amyotrophic lateral sclerosis: new developments in diagnostic markers.  Neurodegener Dis. 2005;  2 177-184
    CrossrefPubMedGoogle Scholar
  • 31 Eisen A, Stewart H. Not-so-benign fasciculation.  Ann Neurol. 1994;  35 375-376
    PubMedGoogle Scholar
  • 32 Dengler R. Neue Überlegungen zur klinisch-neurophysiologischen Diagnostik bei ALS. Die Awaji-Kriterien.  Klinische Neurophysiologie. 2008;  39 164-168
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 de Carvalho M. et al . Electrodiagnostic criteria for diagnosis of ALS.  Clin Neurophysiol. 2008;  119 497-503
    CrossrefPubMedGoogle Scholar
  • 34 Jaspert A. et al . Multifocal motor neuropathy: clinical and electrophysiological findings.  J Neurol. 1996;  243 684-692
    CrossrefPubMedGoogle Scholar
  • 35 de Carvalho M. et al . Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;  6 17-28
    CrossrefPubMedGoogle Scholar
  • 36 Dengler R. Klinik und Differenzialdiagnose. In: Dengler R, Ludolph A, Zierz S, Hrsg Amyotrophe Lateralsklerose. Stuttgart, New York; Thieme Verlag 2000: 59-64
    Google Scholar
  • 37 Urban P P, Vogt T, Hopf H C. Corticobulbar tract involvement in amyotrophic lateral sclerosis. A transcranial magnetic stimulation study.  Brain. 1998;  121 1099-1108
    CrossrefPubMedGoogle Scholar
  • 38 Urban P P, Wicht S, Hopf H C. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in Amyotrophic Lateral Sclerosis (ALS).  J Neurol. 2001;  248 850-855
    CrossrefPubMedGoogle Scholar
  • 39 Claus D. et al . Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis.  J Neurol Sci. 1995;  129 (Suppl.) 30-34
    CrossrefPubMedGoogle Scholar
  • 40 Chen R. et al . The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee.  Clin Neurophysiol. 2008;  119 504-532
    CrossrefPubMedGoogle Scholar
  • 41 Komissarow L. et al . Triple stimulation technique (TST) in amyotrophic lateral sclerosis.  Clin Neurophysiol. 2004;  115 356-360
    CrossrefPubMedGoogle Scholar
  • 42 Kollewe K, Andersen P M, Borasio G D. et al . Klinische Leitlinien zur Behandlung der Amyotrophen Lateralsklerose.  Nervenheilkunde. 2008;  4 302-316
    PubMedGoogle Scholar
  • 43 Johnson W G. Hexosaminidase deficiency: a cause of recessively inherited motor neuron diseases.  Adv Neurol. 1982;  36 159-164
    PubMedGoogle Scholar
  • 44 Bensimon G, Lacomblez l, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS / Riluzole Study Group.  N Engl J Med. 1994;  330 585-591
    CrossrefPubMedGoogle Scholar
  • 45 Lacomblez L. et al . Long-term safety of riluzole in amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;  3 23-29
    CrossrefPubMedGoogle Scholar
  • 46 Lacomblez L. et al . Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis / Riluzole Study Group II.  Lancet. 1996;  347 1425-1431
    CrossrefPubMedGoogle Scholar
  • 47 Lacomblez L. et al . A confirmatory dose-ranging study of riluzole in ALS. ALS / Riluzole Study Group-II.  Neurology. 1996;  47 (6, Suppl. 4) S242-250
    CrossrefPubMedGoogle Scholar
  • 48 Traynor B J. et al . An outcome study of riluzole in amyotrophic lateral sclerosis – a population-based study in Ireland 1996–2000.  J Neurol. 2003;  250 473-479
    PubMedGoogle Scholar
  • 49 Turner M R. et al . Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;  3 15-21
    CrossrefPubMedGoogle Scholar
  • 50 Gurney M E. Transgenic-mouse model of amyotrophic lateral sclerosis.  N Engl J Med. 1994;  331 1721-1722
    CrossrefPubMedGoogle Scholar
  • 51 Gurney M E. et al . Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.  Science. 1994;  264 1772-1775
    CrossrefPubMedGoogle Scholar
  • 52 Schutz B. et al . The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.  J Neurosci. 2005;  25 7805-7812
    CrossrefPubMedGoogle Scholar
  • 53 Forshew D A, Bromberg M B. A survey of clinicians' practice in the symptomatic treatment of ALS.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;  4 258-263
    CrossrefPubMedGoogle Scholar
  • 54 Giess R. et al . Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.  J Neurol Neurosurg Psychiatry. 2000;  69 121-123
    Google Scholar
  • 55 Sancho J. et al . Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.  Chest. 2004;  125 1400-1405
    CrossrefPubMedGoogle Scholar
  • 56 Heffernan C. et al . Nutritional management in MND / ALS patients: an evidence based review.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;  5 72-83
    CrossrefPubMedGoogle Scholar
  • 57 Kubler A. et al . Brain-computer communication: self-regulation of slow cortical potentials for verbal communication.  Arch Phys Med Rehabil. 2001;  82 1533-1539
    CrossrefPubMedGoogle Scholar
  • 58 Kubler A. et al . Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface.  Neurology. 2005;  64 1775-1777
    CrossrefPubMedGoogle Scholar
  • 59 Lyall R A. et al . Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.  Brain. 2001;  124 2000-2013
    CrossrefPubMedGoogle Scholar
  • 60 Bourke S C. et al . Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.  Lancet Neurol. 2006;  5 140-147
    CrossrefPubMedGoogle Scholar
  • 61 Miller R G. et al . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.  Neurology. 1999;  52 1311-1323
    PubMedGoogle Scholar
  • 62 Kuhnlein P. et al . Palliative care and circumstances of dying in German ALS patients using non-invasive ventilation.  Amyotroph Lateral Scler. 2008;  9 91-98
    CrossrefPubMedGoogle Scholar
  • 63 Brooks B R. et al . Treatment of pseudobulbar affect in ALS with dextromethorphan / quinidine: a randomized trial.  Neurology. 2004;  63 1364-1370
    CrossrefPubMedGoogle Scholar

Prof. Dr. Susanne Petri

Neurologische Klinik der Medizinischen Hochschule Hannover

Carl-Neuberg-Straße 1

30625 Hannover

Email: Petri.Susanne@mh-hannover.de

      >